Effect of Exoskeleton-Assisted Walking on Gait Parameters in Healthy Adults (EKSO-GAIT)

March 24, 2026 updated by: Sebastian Glowinski, The State Academy of Applied Sciences in Koszalin

Immediate Effects of a Single Session of Exoskeleton-Assisted Walking on Plantar Pressure Distribution and Gait Parameters in Healthy Young Adults

This study aims to evaluate the immediate effects of a single session of exoskeleton-assisted walking on gait parameters and plantar pressure distribution in healthy young adults. Participants will undergo baseline gait assessment using a baropodometric platform, followed by a 30-minute walking session using the Ekso NR exoskeleton. Immediately after the intervention, gait assessment will be repeated. The study is designed as a single-group, pre-post experimental evaluation of biomechanical changes associated with exoskeleton use.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The purpose of this study is to investigate the immediate biomechanical effects of exoskeleton-assisted walking in healthy individuals. A total of 25 healthy adult participants will be recruited. After screening for eligibility, participants will complete a questionnaire and undergo baseline gait analysis using a baropodometric platform (FreeStep).

Following the baseline assessment, participants will perform a 30-minute walking session using the Ekso NR wearable exoskeleton under supervision. Immediately after completing the session, gait analysis will be repeated using the same baropodometric platform.

Primary outcomes will include changes in plantar pressure distribution parameters, while secondary outcomes will include changes in spatiotemporal gait parameters such as step length, cadence, and symmetry.

The study is designed as a single-arm, pre-post interventional study focusing on biomechanical assessment rather than therapeutic intervention. The results will contribute to understanding the effects of exoskeleton-assisted walking on gait in healthy individuals.

Study Type

Interventional

Enrollment (Estimated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults aged 19-25 years
  • No history of musculoskeletal or neurological disorders
  • Ability to walk independently

Exclusion Criteria:

  • Any current injury affecting gait
  • Neurological or orthopedic conditions
  • Contraindications to exoskeleton use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exoskeleton Walking
Participants undergo baseline gait assessment, followed by a 30-minute walking session using an exoskeleton, and a post-intervention assessment.
Device: Ekso NR Exoskeleton
A wearable robotic exoskeleton used to assist walking during a supervised 30-minute session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in plantar pressure distribution
Time Frame: Immediately before and immediately after intervention
Assessment of plantar pressure parameters measured using a baropodometric platform before and immediately after exoskeleton-assisted walking [kg/cm^2].
Immediately before and immediately after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in spatiotemporal gait parameter
Time Frame: Immediately before and immediately after intervention
Evaluation of step length [m]
Immediately before and immediately after intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in symmetry
Time Frame: Immediately before and immediately after intervention
Change in symmetry [%] using baropodometric analysis
Immediately before and immediately after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The State Academy of Applied Sciences in Koszalin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

March 20, 2026

First Submitted That Met QC Criteria

March 24, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EKSO_GAIT_2026_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual participant data may be shared upon reasonable request, in accordance with institutional policies and applicable data protection regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gait Analysis in Healthy Subjects

Clinical Trials on Ekso NR Exoskeleton

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe